Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Badger Meter Inc (BMI) vs McKesson Corporation (MCK) Price & Performance

Badger Meter IncTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

Badger Meter Inc vs McKesson Corporation — how do they compare? Badger Meter Inc trades at $141.46 (market cap $4.09B), while McKesson Corporation trades at $801.98 (market cap $95.10B). The key difference: McKesson Corporation is far larger — about 23.3× Badger Meter Inc's market cap, and Badger Meter Inc pays the higher dividend (1.14%). Which is the better fit depends on your goals.

BMIMCK
Market Cap
$4.09B$95.10B
Sector
TechnologyHealth
52-Week High
$245.81$995.69
52-Week Low
$113.41$659.01
Enterprise Value
$3.88B$99.74B
Dividend Yield
1.14%0.4%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Badger Meter Inc

No Aura AI signal available yet.

McKesson Corporation

McKesson (MCK) trades at $812.28, up 0.78% with a bullish technical signal. The stock shows consistent earnings beats, with Q1 2026 EPS of $11.69 exceeding expectations. Revenue grew to $359.05B in 2025, though net margins remain thin at 1.18%. Analysts maintain strong buy consensus (80%) with a $932.83 price target. Recent news highlights growth in specialty pharma and oncology services, supporting positive momentum.

Outlook remains positive driven by earnings strength and sector tailwinds, but risks include policy changes and high liabilities. The stock offers value with a P/E of 21.16 and P/S of 0.25, though investors should monitor debt levels and execution risks amid competitive pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Badger Meter Inc

Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.

Read more on BMI

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK